Reply by Authors (2020)

No AccessJournal of UrologyAdult Urology1 Sep 2020Reply by Authors Daniel M. Geynisman, Brian T. Kadow, Brian M. Shuch, Stephen A. Boorjian, Surena F. Matin, Edward Rampersaud, Barton N. Milestone, Elizabeth R. Plimack, Matthew R. Zibelman, Alexander Kutikov, Marc C. Smaldone, David YT Chen, Rosalia Viterbo, Shreyas Joshi, Richard E. Greenberg, Lois Malizzia, Thomas McGowan, Eric A. Ross, and Robert G. Uzzo Daniel M. GeynismanDaniel M. Geynisman Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , Brian T. KadowBrian T. Kadow Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , Brian M. ShuchBrian M. Shuch Yale University, New Haven, Connecticut More articles by this author , Stephen A. BoorjianStephen A. Boorjian Mayo Clinic, Rochester, Minnesota More articles by this author , Surena F. MatinSurena F. Matin MD Anderson Cancer Center, Houston, Texas More articles by this author , Edward RampersaudEdward Rampersaud Duke University, Durham, North Carolina More articles by this author , Barton N. MilestoneBarton N. Milestone Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , Elizabeth R. PlimackElizabeth R. Plimack Fox Chase Cancer Center, Philadelphia, Pennsylvania Financial interest and/or other relationship with Flatiron, Genentech, Merck, Seattle Genetics, AstraZeneca, Pfizer, Infinity Pharma, American Urological Association, Clinical Care Options, Fox Chase Cancer Center, Georgetown, Medscape, NCCN®, PER, PriME Oncology, Research to Practice, University of Pennsylvania, GU ASCO, Astellas and BMS. More articles by this author , Matthew R. ZibelmanMatthew R. Zibelman Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , Alexander KutikovAlexander Kutikov Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , Marc C. SmaldoneMarc C. Smaldone Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , David YT ChenDavid YT Chen Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , Rosalia ViterboRosalia Viterbo Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , Shreyas JoshiShreyas Joshi Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , Richard E. GreenbergRichard E. Greenberg Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , Lois MalizziaLois Malizzia Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , Thomas McGowanThomas McGowan Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , Eric A. RossEric A. Ross Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , and Robert G. UzzoRobert G. Uzzo †Correspondence: Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, Pennsylvania 19111 telephone: 215-728-3096; FAX: 215-214-4035; E-mail Address: [email protected] Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001065.02AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Reply by Authors." The Journal of Urology, 204(3), pp. 536–537 © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 204Issue 3September 2020Page: 536-537 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Daniel M. Geynisman Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Brian T. Kadow Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Brian M. Shuch Yale University, New Haven, Connecticut More articles by this author Stephen A. Boorjian Mayo Clinic, Rochester, Minnesota More articles by this author Surena F. Matin MD Anderson Cancer Center, Houston, Texas More articles by this author Edward Rampersaud Duke University, Durham, North Carolina More articles by this author Barton N. Milestone Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Elizabeth R. Plimack Fox Chase Cancer Center, Philadelphia, Pennsylvania Financial interest and/or other relationship with Flatiron, Genentech, Merck, Seattle Genetics, AstraZeneca, Pfizer, Infinity Pharma, American Urological Association, Clinical Care Options, Fox Chase Cancer Center, Georgetown, Medscape, NCCN®, PER, PriME Oncology, Research to Practice, University of Pennsylvania, GU ASCO, Astellas and BMS. More articles by this author Matthew R. Zibelman Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Alexander Kutikov Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Marc C. Smaldone Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author David YT Chen Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Rosalia Viterbo Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Shreyas Joshi Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Richard E. Greenberg Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Lois Malizzia Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Thomas McGowan Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Eric A. Ross Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author Robert G. Uzzo Fox Chase Cancer Center, Philadelphia, Pennsylvania †Correspondence: Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, Pennsylvania 19111 telephone: 215-728-3096; FAX: 215-214-4035; E-mail Address: [email protected] More articles by this author Expand All Advertisement PDF downloadLoading ...